Sartorius Stedim Biotech S.A. (ETR:56S1)
Germany
· Delayed Price · Currency is EUR 168.05
+2.65 (1.60%)
Last updated: Apr 15, 2025
Sartorius Stedim Biotech Revenue
In the year 2024, Sartorius Stedim Biotech had annual revenue of 2.78B EUR with 0.16% growth. Sartorius Stedim Biotech had revenue of 751.30M in the quarter ending December 31, 2024, with 6.30% growth.
Revenue
2.78B
Revenue Growth
+0.16%
P/S Ratio
6.05
Revenue / Employee
280.78K
Employees
9,901
Market Cap
16.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.78B | 4.50M | 0.16% |
| Dec 31, 2023 | 2.78B | -717.20M | -20.53% |
| Dec 31, 2022 | 3.49B | 605.70M | 20.98% |
| Dec 31, 2021 | 2.89B | 976.92M | 51.15% |
| Dec 31, 2020 | 1.91B | 469.51M | 32.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 34.18B |
| Deutsche Telekom AG | 118.43B |
| Siemens Aktiengesellschaft | 76.54B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 9.75B |
| Merck KGaA | 21.16B |
| Deutsche Börse AG | 5.80B |